candidates across oncology and immunology Exscientia will receive an upfront cash payment of $100 million

License Agreement Neurocrine Biosciences has agreed to pay Sosei Heptares an upfront payment of US$100 million

decades—but the two-year-old biotech believes the area is still ripe for development, and it now has $100 million

., today announced it closed an oversubscribed $33 million financing round, extending its $100 million

Cancer Research UK , a charity dedicated to funding lifesaving oncology research, spent £388 million

The move comes less than three weeks after X4 pulled together a $55 million PIPE and amended a loan facility

, Abbie Celniker was promoted to partner at Third Rock Ventures as the firm raised just over $600 million

underwriting discounts and commissions and other offering expenses, are expected to be approximately $125.0 million